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Drug abuse is a major domestic health problem in the United States, and evaluators, 
policy makers, interest groups, and the general public are critically interested in 
knowing which treatments work best. Costs of drug abuse in America are conserva- 
tively estimated at 47 billion dollars per year (Harwood, 1984). It is estimated that 
over 27 million persons in households in the United States, or about one in every ten 
Americans, used illicit drugs in 1990 (National Institute on Drug Abuse, 1991). 
The Drug Abuse Reporting Program (DARP) and the Treatment Outcome Pro- 
spective Study (TOPS) represent two major drug abuse treatment outcome studies. 
The DARP study tracked over 44,000 drug users admitted to 52 drug abuse treatment 
programs during 1969-1973. DARP found that demographic and socioeconomic 
characteristics explained only a small amount of outcome variance (Sells and Simp- 
son, 1980). Better predictors of treatment outcome were the length of time in treat- 
ment and the behavior during treatment (Simpson et al., 1982). 
TOPS included 11,750 drug users admitted to 41 drug abuse programs during 
1979-l 98 1. A finding from this study was that drug abuse treatment reduced illicit 
drug use and criminal behavior (Hubbard et al., 1989). As in DARP, time in treatment 
was positively related to drug abuse treatment outcome. 
While the DARP and TOPS studies established the effectiveness of drug abuse 
treatment, many issues remain to be clarified. For example, more work is needed in 
efforts to match clients to treatment. The study of treatment process has remained 
tantalizingly difficult and little is known about the role that treatment structure and 
organization play in treatment outcome (Tims and Ludford, 1984). 
The purpose of this paper is to report data about outpatient treatment unit follow- 
up evaluations drawn from selected evaluation items in the recent National Drug 
Abuse Treatment Survey. A section of questions related to treatment evaluation activ- 
ities was included in this national survey of drug abuse treatment programs. These 
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questions provided information on a number of variables critical to program evalua- 
tion. 
METHOD 
This study uses self-report data from a national survey of outpatient drug abuse treat- 
ment units conducted in the Fall of 1988 by the University of Michigan’s Institute for 
Social Research. The sample of units for the national study (N = 670) was a stratified 
random sample drawn from a list of the population of treatment units in the United 
States in 1988 (A’ = 6,8S 1). The population of units was stratified according to treat- 
ment modality (methadone vs. non-methadone); ownership (public, private for-profit, 
private not-for-profit): and setting (hospital-based, mental health center based, free- 
standing facility). 
The unit directors and clinical supervisors of each of the 670 selected treatment 
units were asked to complete phone surveys, Directors provided information con- 
cerning the unit’s ownership, finances, and goals. Clinical supervisors provided infor- 
mation about staff members, clients, and services. The response rate was 85.8% (N = 
575). Units not doing follow-up evaluation did not complete the evaluation questions. 
The number of usable respondents, i.e., those program directors who indicated they 
made some follow-up, was 377. The evaluation items of interest for this study were 
contained in Section “D” of the “Director’s Questionnaire.” The major topics exam- 
ined included the following: 
. Follow-up Data Obtained 
. Time Periods of Follow-up Data 
. Successful Collection of Follow-up Data 
. Types of Follow-up Data 
. Means of Data Collection 
. Changes Made 
The response options were either a five part response menu that ranged from “no 
extent” to “a very high extent” or a yes/no format. Self-report data were not verified 
by actual visitation at the outpatient drug abuse treatment programs. The variables 
selected were related to collecting follow-up data after treatment ended. The vari- 
ables assessed if, when, how, by whom, and what follow-up data were collected, as 
well as whether comparisons were made with other units, based on the follow-up data 
and changes made as a result of the comparisons. 
RESULTS 
The first and most notable finding is that only 66% of the units were collecting any 
follow-up data and only 27% said they were following up to any great extent. Future 
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TABLE 1. At What Points Does Your Unit Typically Obtain Follow-up Information 
on Its Outpatient Substance Abuse Clients After They End Treatment? 
Time Period Number- of Units 
l-3 months 60.2 
4-6 months 45.9 
7-9 months II.1 
IO-12 months 34.7 
13-l 8 months 6.6 
19-24 months 4.x 










research might concentrate on exploring what barriers to the collection of follow-up 
data exist. If lack of resources is an issue, then financial incentives may prove help- 
ful. 
The largest number of follow-ups were conducted in the earliest time period (l-3 
months) after the patient leaves treatment (Table 1); with fewer conducted as the time 
from termination lengthens (24 or more months). A third of the programs targeted a 
one-year follow-up interval, but less than one in ten programs (8.2%) were collecting 
follow-up data longer than eighteen months after clients exited the program. Also, 
only 18% said they experienced success to any great extent in their follow-up efforts 
(Table 2). 
The most frequently collected information (96.5%) was post-treatment drug or 
alcohol use (Table 3). Other types of data collected by four out of five programs 
which collected any follow-up information (as reported by the program directors) 
were, in order of decreasing frequency: clients in recommended treatment (89.9%), 
the client’s employment status (85.1%), the client’s evaluation of the treatment expe- 
rience (8 1.4%), and the client’s health status (80.9%). 
Of the various specifically identified methods, the most labor intensive method 
(face to face interviews) was the least often used (58.5%). Less labor intensive meth- 
ods such as telephone follow-up (75.3%) and self-administered survey (68.1%) were 
more frequently used (Table 4). 
TABLE 2. To What Extent Is the Collection of Follow-up Data Successful for All Out- 
patient Substance Abuse Clients for Whom Your Unit Attempts to Obtain Follow-up 
Data? 
E.vtent Percentage Number of Units 
None 2.7 IO 
Little 30.0 Ill 
Some 49.5 I83 
Great 15.4 57 
Very great 2.4 9 
Total 370 
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TABLE 3. Please Tell Me Which of the Following Kinds of Follow-up Information 
Are Obtained for Your Unit’s Outpatient Substance Abuse Clients 
Drug or alcohol ux 
In recommended treatment 
Employment 
Client evaluation of trwtnit’nt 
exprriencc 
Health aaus 
Legal probation status 
Living arrangements 
Client evaluation of the agency 
in general 
Informntion to get drop outs to 








TABLE 4. Is This Information Collected Through: 
Mccllr \ Pwc~or/rrpc’ 
Tclcphone tollou-up 75.3 2X1 
Sell-ndrnin\t~~-ed wrvq \ 6X. I ‘56 
Face-to-kicc interview\ sx.5 I??() 
Othel 36.0 IOI 
TABLE 5. To What Extent Does Your Unit Use This Follow-up Information to Make 
Changes in Your Outpatient Unit’s Substance Abuse Programs? 
Clearly. the ma_jority of programs collecting follow-up information were 
reported to make changes based on follow-up data, at least a “little” (04.7%‘). Also. 
about one third (34.2% ) use follow-up data to make changes to a “great” or “very 
great” extent (Table 5). What sort of “changes” were made need% to be further 
explored. For example. different hours for program intake activities may be a 
“change.” but it is not of the same order of magnitude as switching therapeutic 
modalities. 
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DISCUSSION 
These data are both cause for encouragement and cause for concern. In these days of 
cost containment and very tight budgets, that any sort of evaluations were conducted 
in drug abuse treatment programs is a hopeful sign. Indeed, many drug abuse pro- 
grams are reported by program directors to be involved in evaluation activities. Many 
of these program directors may recognize the value of drug abuse treatment evalua- 
tion activities and be willing to devote a proportion of their scarce resources of time 
and personnel to collect follow-up data and make comparisons and changes. It would 
certainly be a hopeful development for the field of drug abuse treatment research if 
this perception were a reflection of the clinical reality (Tims and Ludford, 1984). 
On the other hand, while many program directors report a degree of involvement 
in drug abuse treatment evaluation related activities, the extent of involvement is 
rarely very great. In all likelihood, scarcity of person-power and time are reasons for 
the less than ideal degree of evaluation activity in this area. More research, however, 
is needed to determine what other barriers exist to preclude effective drug abuse pro- 
gram evaluation. For example, an absence of technical expertise in program evalua- 
tion by regular program staff and the lack of appropriate evaluation instruments could 
be impediments to effective drug abuse treatment evaluation. 
To further encourage evaluation efforts in the drug abuse field, a number of 
things could be done. For example, certification and licensing could be linked to 
meaningful involvement in evaluation, and, specific resources could be ear-marked 
for support of evaluation tasks. However, additional research needs to be conducted 
to determine what would encourage directors to conduct more meaningful evaluation 
activities. 
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